T stage | Initial clinical Staging: n (%) | Relative up-staging by PSMA-PET-imaging: n (%) | Relative down-staging by PSMA-PET-imaging: n (%) | PSMA-PET-imaging staging: n (%) |
---|---|---|---|---|
Biopsy T1c | 6 (40.0) | 1 (6.7) | 1 (6.7) | 0 |
Low risk (≤T2a) | 0 | 0 | 0 | 2 (13.3) |
Intermediate risk (T2b) | 2 (13.3) | 1 (6.7) | 0 | 1 (6.7) |
High risk (≥T2c) | 7 (46.7) | 4 (26.7) | 1 (6.7) | 12 (80.0) |